Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 73-80

  Sullivan, Lisa M ^a   Yankovich, Theresa ^a   Le, Paul ^a   Martinez, Daniel ^a   Santi, Mariarita ^a   Biegel, Jaclyn A ^a,b   Pawel, Bruce R ^a   Judkins, Alexander R ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

atypical teratoid rhabdoid tumor; Claudin 6; malignant rhabdoid tumor; pediatric tumor; small round blue cell tumor

Indexed keywords

CLAUDIN; CLAUDIN 6; TUMOR MARKER;

ADOLESCENT; ARTICLE; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; FETUS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NEOPLASM; RHABDOID TUMOR; SOFT TISSUE TUMOR; TISSUE MICROARRAY;

ADOLESCENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CLAUDINS; FETUS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS; RHABDOID TUMOR; SOFT TISSUE NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84355166631     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822cfa7e     Document Type: Article

References (34)

1. Abuazza G, Becker A, Williams SS, et al. Claudins 6, 9, and 13 are developmentally expressed renal tight junction proteins. Am J Physiol Renal Physiol. 2006;291:F1132-F1141. (Pubitemid 44887225)
2. Angelow S, Ahlstrom R, Yu AS. Biology of claudins. Am J Physiol Renal Physiol. 2008;295:F867-F876.
3. Antonelli M, Hasselblatt M, Haberler C, et al. Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors. Brain Pathol. 2011. Epub ahead of print.
4. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74-79. (Pubitemid 29062960)
5. Birks DK, Kleinschmidt-Demasters BK, Donson AM, et al. Claudin 6 is a positive marker for atypical teratoid/rhabdoid tumors. Brain Pathol. 2010;20:140-150.
6. Bourdeaut F, Freneaux P, Thuille B, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323-330. (Pubitemid 46172708)
7. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652. (Pubitemid 351744839)
8. D'Souza T, Sherman-Baust CA, Poosala S, et al. Age-related changes of claudin expression in mouse liver, kidney, and pancreas. J Gerontol A Biol Sci Med Sci. 2009;64:1146-1153.
9. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7-15.
10. Escudero-Esparza A, Jiang WG, Martin TA. The Claudin family and its role in cancer and metastasis. Front Biosci. 2011;16:1069-1083.
11. Fruhwald MC, Hasselblatt M, Wirth S, et al. Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer. 2006;47:273-278. (Pubitemid 44148043)
12. Hashizume A, Ueno T, Furuse M, et al. Expression patterns of claudin family of tight junction membrane proteins in developing mouse submandibular gland. Dev Dyn. 2004;231:425-431. (Pubitemid 39238069)
13. Hasselblatt M, Gesk S, Oyen F, et al. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) Expression. Am J Surg Pathol. 2011;35:933-935.
14. Heiskala M, Peterson PA, Yang Y. The roles of claudin superfamily proteins in paracellular transport. Traffic. 2001;2:93-98.
15. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer. 2006;6:186.
16. Hoot AC, Russo P, Judkins AR, et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004;28:1485-1491. (Pubitemid 39425515)
17. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33:542-550.
18. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004;28:644-650. (Pubitemid 38579568)
19. Kleinschmidt-Demasters BK, Alassiri AH, Birks DK, et al. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not Claudin 6. Am J Surg Pathol. 2010;34:341-354.
20. Kohashi K, Oda Y, Yamamoto H, et al. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol. 2010;23:981-990.
21. Kreiger PA, Judkins AR, Russo PA, et al. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol. 2009;22:142-150.
22. Morita K, Furuse M, Fujimoto K, et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA. 1999;96: 511-516. (Pubitemid 29061239)
23. Morita K, Sasaki H, Furuse M, et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol. 1999;147:185-194. (Pubitemid 30211806)
24. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. 2003;161:653-660. (Pubitemid 36578587)
25. Sawada N, Murata M, Kikuchi K, et al. Tight junctions and human diseases. Med Electron Microsc. 2003;36:147-156. (Pubitemid 37288275)
26. Schneppenheim R, Fruhwald MC, Gesk S, et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet. 2010;86:279-284.
27. Toth G, Zraly CB, Thomson TL, et al. Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor. Genes Chromosomes Cancer. 2011;50:379-388.
28. Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, et al. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer. 2009;52:328-334.
29. Turksen K, Troy TC. Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium. Dev Dyn. 2001;222:292-300. (Pubitemid 32937601)
30. Turksen K, Troy TC. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development. 2002;129:1775-1784. (Pubitemid 34874193)
31. Vare P, Soini Y. Twist is inversely associated with claudins in germ cell tumors of the testis. APMIS. 2010;118:640-647.
32. ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors. J Neuropathol Exp Neurol. 2011. Epub ahead of print.
33. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature. 1998;394: 203-206. (Pubitemid 28325977)
34. Winter C, Pawel B, Seiser E, et al. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatr Blood Cancer. 2008;51:10-16. (Pubitemid 351717383)